Medicine by Design is accepting expressions of intent (EOIs) for its 2019 New Ideas Awards. These investments focus on seeding new ideas or continuing previously funded Medicine by Design projects that have strong potential to advance regenerative medicine research and translation. Special consideration will be given to proposals that feature:
synthetic biology;
mathematical modelling;
emergent phenomena; and/or
integration of pathophysiological issues (e.g. inflammation, vascularization).
Beyond these topics, Medicine by Design is interested in supporting clinician-led projects that address a specific clinical goal. Proposals are encouraged from investigators who are new to the regenerative medicine community or not leading other Medicine by Design projects. Proposals are encouraged from those who plan to continue developing previously funded Medicine by Design projects.
Each funded project will recieve up to $100,000 per year, for a two-year period from April 1, 2019 to March 31, 2021. Each project must have only one lead principal investigator, and no more than 2 co-investigators. All investigators must have faculty appointment at the University of Toronto.
The EOI template can be downloaded online. Please submit completed EOIs by email to Celine Bauwens by Monday, November 26, 2018 at 5 pm EST. You will be informed within three weeks if your project has been selected to proceed to the full application stage. Only one EOI will be accepted from the same lead investigator.
If you have any questions please contact Celine Bauwens, Scientific Manager.
